Despite its soaring share price, though, Bristol’s underlying business has actually been going through a tumultuous period during this time span. The patent cliff has wreaked havoc on the pharma’s revenue stream, precipitating a major downsizing of its global operations and a pivot toward immuno-oncology as the main focus of the company’s clinical efforts.
Hey, check out all the research scientist jobs. Post your resume today!
